Literature DB >> 14445472

A preliminary report on chlorpromazine in tetanus.

A SHANKER, L S MEHROTRA.   

Abstract

Entities:  

Keywords:  CHLORPROMAZINE/therapy; TETANUS/therapy

Mesh:

Substances:

Year:  1959        PMID: 14445472      PMCID: PMC1990753          DOI: 10.1136/bmj.2.5160.1150

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  12 in total

1.  The action of atropine, promethazine and chlorpromazine on experimental local tetanus in cats and rabbits.

Authors:  W HOUGS; E W ANDERSEN
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1954

2.  Inhibitory actions of chlorpormazine on motor activity.

Authors:  S R DASGUPTA; G WERNER
Journal:  Arch Int Pharmacodyn Ther       Date:  1955-01-01

3.  Chlorpromazine in the treatment of tetanus.

Authors:  E W ANDERSEN; S H JOHANSEN; W HOUGS
Journal:  Dan Med Bull       Date:  1955-05

4.  Chlorpromazine in the management of tetanus.

Authors:  A C COLE; D H ROBERTSON
Journal:  Lancet       Date:  1955-11-19       Impact factor: 79.321

5.  Effect of chlorpromazine on muscle spasm in human tetanus.

Authors:  M N BARR
Journal:  Lancet       Date:  1958-05-10       Impact factor: 79.321

6.  Management of tetanus, using chlorpromazine and mephenesin.

Authors:  J HUTCHINSON; G D HURRELL
Journal:  Br Med J       Date:  1958-08-16

7.  Treatment of tetanus with chlopromazine and nitrous-oxide anaesthesia.

Authors:  R I BODMAN; H J MORTON; E T THOMAS
Journal:  Lancet       Date:  1955-07-30       Impact factor: 79.321

8.  Effect of chlorpromazine on convulsions of experimental and clinical tetanus.

Authors:  R E KELLY; D R LAURENCE
Journal:  Lancet       Date:  1956-01-21       Impact factor: 79.321

9.  The pharmacology of chlorpromazine and promethazine.

Authors:  J H BURN
Journal:  Proc R Soc Med       Date:  1954-08

10.  Mephenesin and combination of mephenesin and chlorpromazine in the management of tetanus: report of 100 cases.

Authors:  J ADRIANI; M KERR
Journal:  South Med J       Date:  1955-08       Impact factor: 0.954

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.